Program - Pfizer (Test) 3  

Program - Pfizer (Test) - UATDR & R12.5.3_S03#Program

Reg - Program: Call Center  

Reg - Program: Call Center

Embed-Program01  

Test_Basrah  

Program v7.2 _Demo  

Program v7.2 (Do Not Touch)

Check Site Phone Validation  

Check Site Phone Validation

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, who are not currently eligible for biologic treatments.

None

None

None